Real-world clinical outcomes of treatment with molnupiravir for patients with mild- to-moderate coronavirus disease 2019 during the Omicron variant pandemic
Suzuki et al., Research Square, doi:10.21203/rs.3.rs-2118653/v1
https://c19early.org/suzuki2v.html